"ギルガメッシュ" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonCivilization 7: Gilgamesh Leader Guide - Phrasemaker
Civilization 7: Gilgamesh Leader Guide Phrasemaker
Civilization 7 - Official Gilgamesh Reveal Trailer - IGN Africa
Civilization 7 - Official Gilgamesh Reveal Trailer IGN Africa
Reminder: Civilization VII Ver. 1.3.2 Update Available Today, Including Gilgamesh - GoNintendo
Reminder: Civilization VII Ver. 1.3.2 Update Available Today, Including Gilgamesh GoNintendo
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin - PR Newswire
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin PR Newswire
AbbVie crowns Gilgamesh its next M&A target with $1B buyout talks: report - Fierce Biotech
AbbVie crowns Gilgamesh its next M&A target with $1B buyout talks: report Fierce Biotech
AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion - statnews.com
AbbVie to buy Gilgamesh’s psychedelic drug for up to $1.2 billion statnews.com
AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug - BioPharma Dive
AbbVie wagers more than $1B on Gilgamesh’s psychedelic drug BioPharma Dive
AbbVie strikes $1.2B deal for Gilgamesh's psychedelic depression therapy - FirstWord Pharma
AbbVie strikes $1.2B deal for Gilgamesh's psychedelic depression therapy FirstWord Pharma
AbbVie signs to acquire Gilgamesh’s bretisilocin for $1.2bn - Pharmaceutical Technology
AbbVie signs to acquire Gilgamesh’s bretisilocin for $1.2bn Pharmaceutical Technology
AbbVie Embraces Psychedelic Drug with Up-to-$1.2B Deal for Gilgamesh’s MDD Candidate - Genetic En...
AbbVie Embraces Psychedelic Drug with Up-to-$1.2B Deal for Gilgamesh’s MDD Candidate Genetic Engineering and Biotechnology News
AbbVie buying Gilgamesh’s psychedelic therapy, planning spinout: Deals Report - biocentury.com
AbbVie buying Gilgamesh’s psychedelic therapy, planning spinout: Deals Report biocentury.com
Unswayed by Cerevel Failure, AbbVie Buys Gilgamesh’s Depression Drug for $1.2B - BioSpace
Unswayed by Cerevel Failure, AbbVie Buys Gilgamesh’s Depression Drug for $1.2B BioSpace
AbbVie completes acquisition of Gilgamesh Pharmaceuticals’ bretisilocin - Yahoo Finance
AbbVie completes acquisition of Gilgamesh Pharmaceuticals’ bretisilocin Yahoo Finance
Pα+ Psychedelic Bulletin #205: AbbVie Eyes Gilgamesh; Psychedelics Use Increases in U.S.; FDA Mov...
Pα+ Psychedelic Bulletin #205: AbbVie Eyes Gilgamesh; Psychedelics Use Increases in U.S.; FDA Moves to Ban Kraton Compound 7-OH; What Is Sinema Selling? Psychedelic Alpha
Fintech-focused Gilgamesh Ventures nabs $20m for Fund II - Venture Capital Journal
Fintech-focused Gilgamesh Ventures nabs $20m for Fund II Venture Capital Journal
AbbVie in talks to acquire Gilgamesh Pharmaceuticals, Bloomberg News reports - Reuters
AbbVie in talks to acquire Gilgamesh Pharmaceuticals, Bloomberg News reports Reuters
AbbVie said to be circling $1B takeout of Gilgamesh: report - FirstWord Pharma
AbbVie said to be circling $1B takeout of Gilgamesh: report FirstWord Pharma
Gilgamesh Pharmaceuticals Announces Positive Topline Phase 2a Results for GM-2505 in Major Depres...
AbbVie tunes in to Gilgamesh's story, inking $1.2B deal for psychedelic program - Fierce Biotech
AbbVie tunes in to Gilgamesh's story, inking $1.2B deal for psychedelic program Fierce Biotech
AbbVie to Acquire Gilgamesh Pharmaceuticals' Bretisilocin, a Novel, Investigational Therapy for M...
Gilgamesh Pharma Announces Positive Topline Phase 2a Results for Blixeprodil (GM-1020) in Major D...
Gilgamesh to close flagship southeast Salem restaurant and brew pub - Statesman Journal
Gilgamesh to close flagship southeast Salem restaurant and brew pub Statesman Journal
AbbVie Finalizes Acquisition of Gilgamesh Pharmaceuticals’ Experimental Drug Bretisilocin - The H...
AbbVie Finalizes Acquisition of Gilgamesh Pharmaceuticals’ Experimental Drug Bretisilocin The Healthcare Technology Report.
Gilgamesh joins a second $1B+ deal with Abbvie - BioWorld MedTech
Gilgamesh joins a second $1B+ deal with Abbvie BioWorld MedTech
6 questions for Andrew Endicott of Gilgamesh Ventures - The Financial Revolutionist
6 questions for Andrew Endicott of Gilgamesh Ventures The Financial Revolutionist
AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisiloc...
AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder Pharmaceutical Executive
Gilgamesh links psychedelic to 94% remission rate in midphase depression trial - Fierce Biotech
Gilgamesh links psychedelic to 94% remission rate in midphase depression trial Fierce Biotech
Gilgamesh’s psychedelic touts 94% remission rate in depression study - Clinical Trials Arena
Gilgamesh’s psychedelic touts 94% remission rate in depression study Clinical Trials Arena
AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health ...
AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market Yahoo Finance
AbbVie (ABBV) in Talks to Acquire Gilgamesh in $1 Billion Deal - bloomberg.com
AbbVie (ABBV) in Talks to Acquire Gilgamesh in $1 Billion Deal bloomberg.com
AbbVie acquires Gilgamesh's psychedelic in $1.2bn depression treatment deal - BioXconomy
AbbVie acquires Gilgamesh's psychedelic in $1.2bn depression treatment deal BioXconomy
AbbVie Nabs Depression Drug From Gilgamesh In $1.2B Deal - Law360
AbbVie Nabs Depression Drug From Gilgamesh In $1.2B Deal Law360
AbbVie could face patent battle over depression asset gained in Gilgamesh deal - Seeking Alpha
AbbVie could face patent battle over depression asset gained in Gilgamesh deal Seeking Alpha
GILGAMESH – AN ANCIENT TALE, A NEW MUSICAL To Receive Research & Development At Guildhall School ...
GILGAMESH – AN ANCIENT TALE, A NEW MUSICAL To Receive Research & Development At Guildhall School BroadwayWorld.com
AbbVie: H1 2025 Earnings Strengthen Case For Targeting Gilgamesh Acquisition (NYSE:ABBV) - Seekin...
AbbVie: H1 2025 Earnings Strengthen Case For Targeting Gilgamesh Acquisition (NYSE:ABBV) Seeking Alpha
AbbVie Buys Phase II MDD Candidate From Gilgamesh, But Not The Company - Citeline News & Insights
AbbVie Buys Phase II MDD Candidate From Gilgamesh, But Not The Company Citeline News & Insights
Fintech venture firm Gilgamesh Ventures raises $20M Fund II - Axios
Fintech venture firm Gilgamesh Ventures raises $20M Fund II Axios
Irkalla: Gilgamesh's Dream - TIFF - Toronto International Film Festival
Irkalla: Gilgamesh's Dream TIFF - Toronto International Film Festival
AbbVie in Talks to Buy Gilgamesh Pharmaceuticals for $1 Billion - Yahoo Finance
AbbVie in Talks to Buy Gilgamesh Pharmaceuticals for $1 Billion Yahoo Finance
Korypheus – Gilgamesh (M-Theory Audio) - Dead Rhetoric
Korypheus – Gilgamesh (M-Theory Audio) Dead Rhetoric
Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks - MSN
Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks MSN
AbbVie to buy Gilgamesh drug candidate in $1.2B deal - Axios
The Stunning, Gorgeous Return of “King Gilgamesh & the Man of the Wild” at Soulpepper Toronto - f...
The Stunning, Gorgeous Return of “King Gilgamesh & the Man of the Wild” at Soulpepper Toronto front mezz junkies
Gilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major Depressive D...
Gilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major Depressive Disorder Study Psychedelic Alpha
AbbVie in talks to acquire psychiatric pharma Gilgamesh in $1 billion deal - Crain's Chicago Busi...
AbbVie in talks to acquire psychiatric pharma Gilgamesh in $1 billion deal Crain's Chicago Business
Locarno 2025 Interview: IRKALLA: GILGAMESH'S DREAM Director Mohamed Al-Daradji on Casting Real Or...
AbbVie to Buy Gilgamesh Depression Drug for Up to $1.2 Billion - bloomberg.com
AbbVie to Buy Gilgamesh Depression Drug for Up to $1.2 Billion bloomberg.com
AbbVie to buy Gilgamesh’s depression program for up to $1.2B (ABBV:NYSE) - Seeking Alpha
AbbVie to buy Gilgamesh’s depression program for up to $1.2B (ABBV:NYSE) Seeking Alpha
Assyrian Arts Institute to Present World Premiere of ‘Gilgamesh’ - OperaWire
Assyrian Arts Institute to Present World Premiere of ‘Gilgamesh’ OperaWire
‘Enkidu’ reinvents the magic of “The Epic of Gilgamesh” centuries later - North by Northwestern
‘Enkidu’ reinvents the magic of “The Epic of Gilgamesh” centuries later North by Northwestern
AbbVie Acquires Gilgamesh’s Psychedelic MDD Program For Up To $1.2B - HIT Consultant
AbbVie Acquires Gilgamesh’s Psychedelic MDD Program For Up To $1.2B HIT Consultant
AbbVie to acquire Gilgamesh Pharma’ mental disorder candidate for $1.2 Bn - ET Pharma
AbbVie to acquire Gilgamesh Pharma’ mental disorder candidate for $1.2 Bn ET Pharma
Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks - Seeking Alpha
Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks Seeking Alpha
Mohamed Al Daradji Reimagines Gilgamesh - Asian Movie Pulse
Mohamed Al Daradji Reimagines Gilgamesh Asian Movie Pulse
AbbVie to buy psychedelic drug from partner Gilgamesh - Endpoints News
AbbVie to buy psychedelic drug from partner Gilgamesh Endpoints News
M&A News: AbbVie Eyes $1B Acquisition of Gilgamesh Therapeutics - TipRanks
M&A News: AbbVie Eyes $1B Acquisition of Gilgamesh Therapeutics TipRanks
'Gilgamesh' opera makes historic debut at Istanbul Opera Festival | Daily Sabah - Daily Sabah
'Gilgamesh' opera makes historic debut at Istanbul Opera Festival | Daily Sabah Daily Sabah
Gilgamesh’s psychedelic drug demonstrates exceptional efficacy for treating depression - Mugglehe...
Gilgamesh’s psychedelic drug demonstrates exceptional efficacy for treating depression Mugglehead Magazine
AbbVie's latest acquisition targets Gilgamesh's psychedelic drug to treat depression - The Busine...
AbbVie's latest acquisition targets Gilgamesh's psychedelic drug to treat depression The Business Journals
‘Gilgamesh’ made its world premiere - Hürriyet Daily News
‘Gilgamesh’ made its world premiere Hürriyet Daily News
AbbVie to Acquire Gilgamesh's Antidepressant Bretisilocin in $1.2 Billion Deal - PharmiWeb.com
AbbVie to Acquire Gilgamesh's Antidepressant Bretisilocin in $1.2 Billion Deal PharmiWeb.com
Irkalla - Gilgamesh's Dream de Mohamed Jabarah Al Daradji (2025) - Unifrance
Irkalla - Gilgamesh's Dream de Mohamed Jabarah Al Daradji (2025) Unifrance
Review: ‘King Gilgamesh’ makes an epic splash at Soulpepper - NEXT Magazine
Review: ‘King Gilgamesh’ makes an epic splash at Soulpepper NEXT Magazine
Real-life story behind Fountain Of Youth: From Gilgamesh to Florida, the myth that inspired Guy R...
Real-life story behind Fountain Of Youth: From Gilgamesh to Florida, the myth that inspired Guy Ritchie’s new movie The Indian Express
Theater review: Marin native creates fascinating adaptation of ‘Gilgamesh’ - Marin Independent Jo...
Theater review: Marin native creates fascinating adaptation of ‘Gilgamesh’ Marin Independent Journal
Gypsy & the Cat and the ‘Epic of Gilgamesh’ - PopMatters
Gypsy & the Cat and the ‘Epic of Gilgamesh’ PopMatters
Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance N...
AbbVie inks $2B-plus next-gen neuro deal with Gilgamesh - Fierce Biotech
AbbVie inks $2B-plus next-gen neuro deal with Gilgamesh Fierce Biotech
Gilgamesh Brewing Auction Notice. Pubs are Still Open - The Washington Beer Blog
Gilgamesh Brewing Auction Notice. Pubs are Still Open The Washington Beer Blog
Auction begins for Gilgamesh Brewing equipment as company downsizes - Statesman Journal
Auction begins for Gilgamesh Brewing equipment as company downsizes Statesman Journal
Assyrian Australian Association to host the Gilgamesh Festival at Sydney University’s 175th Anniv...
Assyrian Australian Association to host the Gilgamesh Festival at Sydney University’s 175th Anniversary. SBS Australia
Gilgamesh Pharmaceuticals Announces AbbVie Collaboration Up to Over $2 Billion - Ropes & Gray LLP
Gilgamesh Pharmaceuticals Announces AbbVie Collaboration Up to Over $2 Billion Ropes & Gray LLP
King Gilgamesh Sizzles at Soulpepper Theatre: REVIEW - Torontonicity
King Gilgamesh Sizzles at Soulpepper Theatre: REVIEW Torontonicity
Gilgamesh to initiate Phase IIa trial of fast-acting psychedelic drug - Clinical Trials Arena
Gilgamesh to initiate Phase IIa trial of fast-acting psychedelic drug Clinical Trials Arena
Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments - PR Ne...
Gilgamesh Pharmaceuticals Raises $39 Million Series B to Advance Mental Health Treatments PR Newswire
AbbVie makes a play for psychiatric treatments with $2bn Gilgamesh collaboration - Pharmaceutical...
AbbVie makes a play for psychiatric treatments with $2bn Gilgamesh collaboration Pharmaceutical Technology
At Gilgamesh, a Taste of Iraq and the Flavors of Home - D Magazine
At Gilgamesh, a Taste of Iraq and the Flavors of Home D Magazine
TTYL: Glory and Gilgamesh - stanforddaily.com
TTYL: Glory and Gilgamesh stanforddaily.com
Why Gilgamesh failed: the mechanistic basis of the limits to human lifespan - Nature
Why Gilgamesh failed: the mechanistic basis of the limits to human lifespan Nature
‘The Epic of Gilgamesh’: The First Great Work of Literature - Medium
‘The Epic of Gilgamesh’: The First Great Work of Literature Medium
Gilgamesh Scoops $14m from NIDA to Develop Safer Ibogaine Analog for Opioid Use Disorder - Psyche...
Gilgamesh Scoops $14m from NIDA to Develop Safer Ibogaine Analog for Opioid Use Disorder Psychedelic Alpha
The epic adventures of the Gilgamesh Dream tablet - BBC
AbbVie takes option on Gilgamesh CNS drugs in $2bn deal - pharmaphorum
AbbVie takes option on Gilgamesh CNS drugs in $2bn deal pharmaphorum
Listen to The Epic of Gilgamesh Being Read in its Original Ancient Language, Akkadian - opencultu...
Listen to The Epic of Gilgamesh Being Read in its Original Ancient Language, Akkadian openculture.com
Ancient Gilgamesh tablet seized from Hobby Lobby by US authorities - The Guardian
Ancient Gilgamesh tablet seized from Hobby Lobby by US authorities The Guardian
Getting through hard times with 10 days of 'The Epic of Gilgamesh' - Iowa City Press-Citizen
Getting through hard times with 10 days of 'The Epic of Gilgamesh' Iowa City Press-Citizen
Gilgamesh Brewing Releases Peanut Butter Mint White Chocolate Imperial Stout - New School Beer + ...
Gilgamesh Brewing Releases Peanut Butter Mint White Chocolate Imperial Stout New School Beer + Cider
Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round - PR Newswire
Gilgamesh Pharmaceuticals Closes On $27 Million Series A Round PR Newswire
Walking Shadow Theatre – “Gilgamesh” and “Beowulf” - Lavender Magazine
Walking Shadow Theatre – “Gilgamesh” and “Beowulf” Lavender Magazine
AbbVie, Gilgamesh Pharmaceuticals Agree to Terms on a Collaboration to Develop Advanced Therapies...
AbbVie, Gilgamesh Pharmaceuticals Agree to Terms on a Collaboration to Develop Advanced Therapies for Psychiatric Disorders Pharmaceutical Executive
Climate Change: From Gilgamesh to Hitchhiker’s Guide to the Galaxy - The Marginalia Review of Books
Climate Change: From Gilgamesh to Hitchhiker’s Guide to the Galaxy The Marginalia Review of Books
UNESCO hails return of looted ancient Gilgamesh tablet to Iraq - news.un.org
UNESCO hails return of looted ancient Gilgamesh tablet to Iraq news.un.org
Did the Bible 'Borrow' the Noah's Ark Story From the Epic of Gilgamesh? - HowStuffWorks
Did the Bible 'Borrow' the Noah's Ark Story From the Epic of Gilgamesh? HowStuffWorks
An ancient clay tablet at Yale has shed light on how the 'Epic of Gilgamesh' has evolved over the...
Richardson Iraqi restaurant Gilgamesh opens new bakery - Community Impact | News
Richardson Iraqi restaurant Gilgamesh opens new bakery Community Impact | News
Michael Schmidt on Gilgamesh - Princeton University Press
Michael Schmidt on Gilgamesh Princeton University Press
Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance N...
SCRUTINY | Soulpepper’s King Gilgamesh & The Man Of The Wild Is Riveting Music & Theatre - ludwig...
SCRUTINY | Soulpepper’s King Gilgamesh & The Man Of The Wild Is Riveting Music & Theatre ludwig-van.com
Gilgamesh, London: ‘It’s a weird trip’ - restaurant review - The Guardian
Gilgamesh, London: ‘It’s a weird trip’ - restaurant review The Guardian
Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals - Psychedelic Alpha
Breaking: AbbVie Inks Deal with Gilgamesh Pharmaceuticals Psychedelic Alpha